First Horizon Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.8M | Buy |
899,279
+74,235
| +9% | +$1.73M | 0.57% | 58 |
|
|
2025
Q1 | $20.9M | Buy |
825,044
+171,713
| +26% | +$4.49M | 0.59% | 57 |
|
|
2024
Q4 | $17.3M | Sell |
653,331
-37,897
| -5% | -$1.03M | 0.49% | 70 |
|
|
2024
Q3 | $20M | Buy |
691,228
+95,749
| +16% | +$2.79M | 0.56% | 62 |
|
|
2024
Q2 | $16.7M | Buy |
595,479
+9,742
| +2% | +$268K | 0.51% | 68 |
|
|
2024
Q1 | $16.3M | Buy |
585,737
+87,584
| +18% | +$2.43M | 0.5% | 66 |
|
|
2023
Q4 | $14.3M | Buy |
498,153
+5,692
| +1% | +$172K | 0.47% | 68 |
|
|
2023
Q3 | $16.3M | Buy |
492,461
+27,071
| +6% | +$957K | 0.59% | 52 |
|
|
2023
Q2 | $17.1M | Buy |
465,390
+18,093
| +4% | +$704K | 0.59% | 49 |
|
|
2023
Q1 | $18.2M | Buy |
447,297
+14,920
| +3% | +$644K | 0.65% | 45 |
|
|
2022
Q4 | $22.2M | Buy |
432,377
+5,629
| +1% | +$270K | 0.82% | 32 |
|
|
2022
Q3 | $18.7M | Sell |
426,748
-7,206
| -2% | -$350K | 0.75% | 35 |
|
|
2022
Q2 | $22.8M | Buy |
433,954
+216,699
| +100% | +$11M | 0.81% | 32 |
|
|
2022
Q1 | $11.2M | Sell |
217,255
-210,698
| -49% | -$10.9M | 0.62% | 42 |
|
|
2021
Q4 | $25.3M | Buy |
427,953
+13,215
| +3% | +$655K | 0.76% | 32 |
|
|
2021
Q3 | $17.8M | Buy |
414,738
+115,930
| +39% | +$5.14M | 0.58% | 49 |
|
|
2021
Q2 | $11.7M | Sell |
298,808
-7,248
| -2% | -$282K | 0.63% | 49 |
|
|
2021
Q1 | $11.1M | Buy |
306,056
+62,926
| +26% | +$2.23M | 0.64% | 48 |
|
|
2020
Q4 | $8.95M | Sell |
243,130
-4,031
| -2% | -$148K | 0.6% | 53 |
|
|
2020
Q3 | $8.61M | Buy |
247,161
+7,709
| +3% | +$270K | 0.64% | 45 |
|
|
2020
Q2 | $7.43M | Buy |
239,452
+11,000
| +5% | +$374K | 0.59% | 50 |
|
|
2020
Q1 | $7.07M | Buy |
228,452
+23,161
| +11% | +$789K | 0.66% | 43 |
|
|
2019
Q4 | $7.63M | Buy |
205,291
+5,328
| +3% | +$190K | 0.56% | 50 |
|
|
2019
Q3 | $6.82M | Sell |
199,963
-6,127
| -3% | -$223K | 0.53% | 51 |
|
|
2019
Q2 | $8.47M | Buy |
206,090
+15,305
| +8% | +$608K | 0.65% | 42 |
|
|
2019
Q1 | $7.69M | Buy |
190,785
+12,040
| +7% | +$482K | 0.62% | 46 |
|
|
2018
Q4 | $7.4M | Sell |
178,745
-25,324
| -12% | -$1.05M | 0.66% | 43 |
|
|
2018
Q3 | $8.53M | Buy |
204,069
+2,656
| +1% | +$102K | 0.66% | 41 |
|
|
2018
Q2 | $6.93M | Buy |
201,413
+19,552
| +11% | +$668K | 0.58% | 53 |
|
|
2018
Q1 | $6.16M | Buy |
181,861
+3,338
| +2% | +$115K | 0.6% | 52 |
|
|
2017
Q4 | $6.14M | Buy |
178,523
+5,152
| +3% | +$176K | 0.58% | 56 |
|
|
2017
Q3 | $5.88M | Buy |
173,371
+50,723
| +41% | +$1.63M | 0.61% | 55 |
|
|
2017
Q2 | $3.9M | Buy |
122,648
+9,725
| +9% | +$307K | 0.42% | 76 |
|
|
2017
Q1 | $3.65M | Sell |
112,923
-13,461
| -11% | -$424K | 0.42% | 76 |
|
|
2016
Q4 | $4.02M | Hold |
126,384
| – | – | 0.51% | 72 |
|
|
2016
Q3 | $4.02M | Buy |
126,384
+3,305
| +3% | +$111K | 0.51% | 72 |
|
|
2016
Q2 | $4.11M | Sell |
123,079
-11,109
| -8% | -$355K | 0.56% | 72 |
|
|
2016
Q1 | $3.89M | Buy |
134,188
+15,047
| +13% | +$430K | 0.43% | 83 |
|
|
2015
Q4 | $3.65M | Sell |
119,141
-2,773
| -2% | -$87.2K | 0.65% | 58 |
|
|
2015
Q3 | $3.63M | Buy |
121,914
+5,970
| +5% | +$191K | 0.56% | 68 |
|
|
2015
Q2 | $3.69M | Sell |
115,944
-13,658
| -11% | -$445K | 0.54% | 71 |
|
|
2015
Q1 | $4.28M | Buy |
129,602
+3,842
| +3% | +$122K | 0.62% | 51 |
|
|
2014
Q4 | $3.72M | Sell |
125,760
-878
| -0.7% | -$25.2K | 0.57% | 57 |
|
|
2014
Q3 | $3.55M | Sell |
126,638
-1,754
| -1% | -$49.2K | 0.55% | 56 |
|
|
2014
Q2 | $3.6M | Buy |
128,392
+9,597
| +8% | +$274K | 0.52% | 59 |
|
|
2014
Q1 | $3.61M | Buy |
118,795
+1,031
| +0.9% | +$30.7K | 0.51% | 53 |
|
|
2013
Q4 | $3.36M | Sell |
117,764
-464
| -0.4% | -$13.5K | 0.5% | 44 |
|
|
2013
Q3 | $3.22M | Buy |
118,228
+112,096
| +1,828% | +$3.05M | 0.52% | 46 |
|
|
2013
Q2 | $163K | Buy |
+6,132
| New | +$169K | 0.08% | 82 |
|
Other funds holding PFE
First Horizon Advisors's PFE Position: Q2 2025 in Review
First Horizon Advisors increased its Pfizer (PFE) stake by 9% in Q2 2025, buying an estimated $1.73M and bringing the position to 899,279 shares worth $21.8M. The position accounts for 0.57% of the portfolio, ranked #58.
First Horizon Advisors first reported a position in PFE in Q2 2013 and has held it in 49 quarters since. The position peaked at $25.3M in Q4 2021. 2,810 funds tracked by Wall St. Rank hold PFE as of Q2 2025.
- First Horizon Advisors held 899,279 shares of Pfizer worth $21.8M as of Q2 2025.
- First Horizon Advisors bought 74,235 Pfizer shares in Q2 2025, an estimated $1.73M.
- Pfizer made up 0.57% of First Horizon Advisors's portfolio in Q2 2025, its #58 holding.
- First Horizon Advisors first reported a position in Pfizer in Q2 2013 and has held it in 49 quarters since.
- First Horizon Advisors's Pfizer position peaked at $25.3M in Q4 2021.
- 2,810 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.
Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.